BerginerV.M, and AbelovichD., Genetics in cerebrotendinous xanthomatosis, Am. J. Med. Genetics, 10:2, 1981.
2.
Van BogaertL.SchererH.J., and EpsteinE., Une Forme Cerebrale de Cholesterinose Generalisee, Masson et Cie, 1937.
3.
MenkesJ.H.SchimschockJ.R., and SwansonP.D., Cerebrotendinous xanthomatosis: The storage of cholestanol within the nervous system, Arch. Neurol., 19:47–53, 1968.
4.
SchimschockJ.R.AlvordE.C., and SwansonP.D., Cerebrotendinous xanthomatosis: Clinical and pathological studies, Arch. Neurol., 18:688–698, 1968.
5.
PhilippartM., and Van BogaertL., Cholestanolosis (cerebrotendinous xanthomatosis), Arch. Neurol., 21:603–610, 1969.
6.
KuritzkyA.BerginerV.M., and KorczynA.D., Peripheral neuropathy in cerebrotendinous xanthomatosis, Neurol., 29:880–881, 1979.
7.
OhnishiA.YamashitaY.GotoI., De- and remyelinization and onion bulb in cerebrotendinous xanthomatosis, Acta Neuropath. (Berlin), 45: 43–45, 1979.
8.
EpsteinE., and LorenzK., Beitrag zur Pathologie und Pathochemie der cholestezinigen Lipoidose von typus Bogaert-Scherer, Klin. Wschr., 16:1320–1323, 1937.
9.
LyonsJ.B., Essential hypercholesterolamic xanthomatosis affecting the nervous system, J. Irish Med. Assn., 37:390–392, 1955.
10.
FarpourH., and MahlondjiM., Familiar cerebrotendinous xanthomatosis: Report of a new family and review of literature, Arch. Neurol, 32:223–225, 1975.
11.
SalenG., Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism, Ann. Int. Med, 75:843–851, 1971.
12.
SalenG.ChengF.ShoreV.ForteT.TintG.S.L and SheferS., Defective high-density lipoprotein in cerebrotendinous xanthomatosis, J. Clin. Invest. (in press).
13.
SalenG.SheferS.ChengF.DayalB.BattaA.K., and TintG.S., Cholic acid biosynthesis. The enzymatic defect in cerebrotendinous xanthomatosis, J. Clin. Invest., 63:38–44, 1979.
14.
BhattacharyyaA.K., and ConnorW.E., Familial disorders with storage of sterols other than cholesterol. Chap. 31. In: StanburyJ.B.WyngaardenJ.B., and FredricksonD.S., eds., The Metabolic Basis of Inherited Disease, New York, McGraw-Hill, 1978.
15.
BerginerV.M.BerginerJ.SalenG.SheferS., and ZimmermanR.D., Computed tomography in cerebrotendinous xanthomatosis, Neurology, 31:1463–1465, 1981.
16.
MuechenhausenC.DerbyB.M., and MoserH.W., Conversion of cholesterol to cholestanol in CTX, Fed. Proc., 28:882, 1969.
17.
StahlW.L.SumiS.M., and SwansonP.D., Subcellular distribution of cerebral cholestanol in cerebrotendinous xanthomatosis, J. Neurochem., 18:403–413, 1971.
18.
HarlanW.R., and StillW.J.S., Hereditary tendinous and tuberous xanthomatosis without hyperlipidemia, N. Engl. J. Med., 278:416–421, 1968.
19.
HughesJ.D. and MeriwetherT.W., Familial pseudohypertrophy of tendo-achilles with multisystem disease, South, Med, J., 64:311–316, 1971.
De JongJ.G.Y.Van GentC.M. and DellemanJ.W., Cerebrotendinous cholestanolosis in relation to other cerebral xanthomatoses, Clin. Neurol. Neurosurg., 79:253–272, 1977.
22.
BerginerV.M., and KorczynA.D., Cerebrotendinous xanthomatosis, Human Heredity, 27:165, 1977.
23.
BerginerV.M.KorczynA.D., and MayersdorfA., Cerebrotendinous xanthomatosis, Harefuah, 92:537–540, 1977.
24.
GibbsF.A., and GibbsE.L., Atlas of EEG, Second edition, Addison-Wesley, Cambridge MA, 1952, pp, 415–424.
25.
CobbW.MartinF., and PampiglioneG., Cerebral lipidosis: An electroencephalographic study, Brain, 75:343–357, 1952.
26.
SchneckL., The early electroencephalographic and seizure characteristics of Tay-Sachs disease, Acta Neurol. Scand., 41:163–171, 1965.
27.
EllingsonR.J., and SchainR.J., EEG patterns in juvenile cerebral lipidosis, Electroenceph. Clin. Neurophysiol., 27:191–194, 1969.